Director at Chemed (NYSE: CHE) receives 386-share stock award

Rhea-AI Filing Summary

Heaney Christopher J reported acquisition or exercise transactions in this Form 4 filing.

CHEMED CORP director Christopher J. Heaney received an equity award of 386 shares of Capital Stock. The award, described as an “Award of stock,” was granted on May 18, 2026 at a price of $440.77 per share. Following this grant, Heaney directly owns 2,775 shares of Chemed capital stock. This is a compensation-related stock award rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Heaney Christopher J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Capital Stock	386	$440.77	$170K

Holdings After Transaction: Capital Stock — 2,775 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock award size: 386 shares Reported share price: $440.77 per share Post-transaction holdings: 2,775 shares

3 metrics

Stock award size 386 shares Capital Stock grant to director on May 18, 2026

Reported share price $440.77 per share Value used for the 386-share stock award

Post-transaction holdings 2,775 shares Heaney’s direct Chemed Capital Stock position after the award

Key Terms

Capital Stock, Grant, award, or other acquisition, Form 4, Award of stock

4 terms

Capital Stock financial

"security_title: "Capital Stock""

Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Award of stock financial

"footnote text: "Award of stock""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Heaney Christopher J

(Last) (First) (Middle)

101 S. FORT LAUDERDALE BEACH BLVD.

APARTMENT 1602

(Street)

FORT LAUDERDALE FLORIDA 33316

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	05/18/2026		A		386	A(1)	$440.77	2,775	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Award of stock

	Christopher J. Heaney	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Chemed (CHE) report for Christopher J. Heaney?

Chemed reported that director Christopher J. Heaney received an award of 386 shares of Capital Stock. This grant was recorded as a compensation-related acquisition rather than an open-market trade, increasing his direct holdings to 2,775 shares after the transaction.

How many Chemed (CHE) shares did Christopher J. Heaney acquire in this Form 4?

Christopher J. Heaney acquired 386 shares of Chemed Capital Stock in this filing. The transaction is coded as a grant or award, reflecting equity compensation, and it raised his direct ownership position to a total of 2,775 shares after the award.

At what price was Christopher J. Heaney’s Chemed (CHE) stock award recorded?

The 386-share stock award to Christopher J. Heaney was recorded at $440.77 per share. This value reflects the price used for reporting purposes in the Form 4 and helps quantify the size of the compensation-related equity grant he received.

What is Christopher J. Heaney’s Chemed (CHE) share ownership after this award?

After receiving the 386-share award, Christopher J. Heaney directly owns 2,775 shares of Chemed Capital Stock. This total reflects his post-transaction holdings as reported in the Form 4 and indicates his ongoing equity stake as a company director.

Was the Chemed (CHE) transaction an open-market purchase or a stock award?

The Chemed transaction was a stock award, not an open-market purchase. It is coded as a grant or award acquisition, and a footnote describes it as an “Award of stock,” indicating compensation rather than a discretionary market trade by the director.